19 November,2020 08:18 AM IST | Washington | Agencies
A woman walks by Pfizer's New York headquarters as city tries to contain a spike in COVID-19 cases. Pic/AFP
Pfizer says more interim results from its ongoing coronavirus vaccine study suggest the shots are 95 per cent effective and that the vaccine protects older people most at risk of dying from COVID-19.
The announcement, just a week after Pfizer first revealed promising preliminary results, comes as the company is preparing within days to formally ask US regulators to allow emergency use of the vaccine.
Pfizer initially had estimated its vaccine, developed with German partner BioNTech, was more than 90 per cent effective after 94 infections had been counted. With Wednesday's announcement, the company now has accumulated 170 infections in the study - and said only eight of them occurred in volunteers who got the actual vaccine rather than a dummy shot. One of those eight developed severe disease, the company said.
The company has not yet released detailed data on its study, and results have not been analysed by independent experts.
ALSO READ
Report finds Boris Johnson deliberately misled UK Parliament over ‘partygate’
Two people stabbed to death in Portugal's Muslim centre; suspect shot, injured
Turkiye president Erodgan ratifies Finland's NATO application
Turkiye, Egypt scramble to mend relations damaged in wake of 2011 Arab Spring
Efforts for routine immunisation back to pre-Covid times: WHO
Pfizer said its vaccine was more than 94 per cent effective in adults over age 65, though it is not clear how the firm determined effectiveness in older adults, with only eight infections in the vaccinated group to analyse and no breakdown provided of those people's ages.
Pfizer says it now has the data on the vaccine's safety needed to seek emergency authorisation from the Food and Drug Administration. Pfizer and BioNTech said they expect to produce up to 50 million vaccine doses globally in 2020 and up to 1.3 billion doses in 2021.
Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
